EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY – Get Free Report) saw a significant growth in short interest in the month of December. As of December 31st, there was short interest totaling 7,240 shares, a growth of 45.5% from the December 15th total of 4,976 shares. Based on an average daily volume of 84,430 shares, the short-interest ratio is presently 0.1 days. Currently, 0.0% of the company’s shares are sold short. Currently, 0.0% of the company’s shares are sold short. Based on an average daily volume of 84,430 shares, the short-interest ratio is presently 0.1 days.
Analyst Ratings Changes
A number of brokerages have recently issued reports on ESLOY. Zacks Research downgraded shares of EssilorLuxottica from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 18th. The Goldman Sachs Group reiterated a “buy” rating on shares of EssilorLuxottica in a research report on Friday, December 5th. Hsbc Global Res upgraded EssilorLuxottica to a “strong-buy” rating in a research report on Wednesday. Kepler Capital Markets upgraded EssilorLuxottica from a “hold” rating to a “buy” rating in a report on Thursday. Finally, Royal Bank Of Canada restated an “outperform” rating on shares of EssilorLuxottica in a report on Tuesday, October 28th. Two equities research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy”.
Get Our Latest Research Report on ESLOY
EssilorLuxottica Stock Down 3.3%
EssilorLuxottica Company Profile
EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.
The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.
See Also
- Five stocks we like better than EssilorLuxottica
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.
